At the 2024 Alzheimers Association International Conference, early results showed that people in early stages of Alzheimers who took the GLP-1 drug liraglutide daily for a year lost almost 50 percent less brain volume in key areas tied to memory and thinking
Losing facial volume and low facial skin elasticity is part of the natural aging process, so they are starting with a disadvantage
Its direct distribution model via LillyDirect and partnerships with telehealth firms have also further expanded its edge
The number of treated obesity cases in Japan has been steadily increasing, with approximately 150,000 treated adult cases and approximately 180 treated children cases in 2025
Cheung WW, Zheng R, Hao S, Wang Z, Gonzalez A, Zhou P, et al
Clues from animal studies and ovarian cells A 2025 review found that in animal studies, GLP-1 RAs sometimes corrected ovarian cycle problems and reduced ovarian follicle cysts